Amphastar Pharmaceuticals Inc (NAS:AMPH)
$ 21.48 +0.47 (+2.21%) Market Cap: 947.12 Mil Enterprise Value: 1.34 Bil PE Ratio: 12.94 PB Ratio: 1.24 GF Score: 83/100

Q1 2026 Amphastar Pharmaceuticals, Inc Earnings Call Transcript

May 7, 2026 / 09:00 PM GMT
Release Date Price: $24.03 (+0.54%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

AMPH.OQ - Amphastar Pharmaceuticals, Inc
Q1 2026 Amphastar Pharmaceuticals, Inc Earnings Call
May 07, 2026 / 09:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Greetings, and welcome to the Amphisar Pharmaceuticals First Quarter Earnings Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. If anyone should require operator assistance during the conference, please press star zero on your telephone keypad.

Please note that certain statements made during this call regarding matters that are not historical facts, including but not limited to management's outlook or predictions for future periods are forward-looking statements. These statements are based solely on information that is now available to us. We encourage you to review the session entitled Forward-Looking Statements in the Press
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot